BioSpace News Archive

Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2021 on Wednesday, May 4 at 9 a.m., ET.

Growing awareness regarding preventive healthcare approaches is driving the revenue growth of the market.

The industry analysis report is considered a valuable source of information about the global Liver Cancer Diagnostics industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

Growing need to eradicate malaria through diagnosis and treatment is expected to fuel market growth.

Rising prevalence of ovarian cancer and growing focus on early detection and treatment are expected to fuel market growth.

Growing adoption of Point-of-care testing services and introduction of home healthcare facilities are key factors fueling global market growth.

Shift in diagnostics from centralized labs toward practitioners’ offices expected to drive market growth.

Increasing prevalence of structural heart diseases and fast-paced adoption of advanced structural heart imaging techniques to accelerate market growth.

Rising prevalence of Zika virus, increasing public awareness, and growing footprint of local manufacturers of rapid tests for Zika virus are key factors boosting global market growth.

Repertoire Immune Medicines announced today that Science Advances published preclinical research demonstrating the company’s cell-tethering technology can deliver the potent cytokine interleukin-12 (IL-12) to solid tumors without eliciting the severe systemic toxicities typically associated with the use of this cytokine.